openPR Logo
Press release

The Meningococcal Vaccines Market to scale high in the next decade

03-01-2021 08:35 AM CET | Health & Medicine

Press release from: Persistence Market Research

The meningococcal vaccine market has expanded to a significant extent over the past few years in correspondence to the parent market. Constant research and development in meningococcal vaccines for various meningococcal disease preventive applications, coupled with the sanctions of subsidy & support of government organizations for immunization program are among the significant factors that are anticipated to drive the growth of the meningococcal vaccine market during the forecast period.

Expansion of the age group indication related to new sero-groups is boosting the potential population pool, thus boosting the market growth. As per the latest research by PMR, the global meningococcal vaccine market is estimated to account for ~ US$ 6.5 billion in terms of revenue by the end of 2029.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3640

Company Profiles:

Sanofi Pasteur Inc.
GlaxoSmithKline
Wyeth Pharmaceuticals
The meningococcal vaccine market report also projects a significant growth prospective with a projected average Y-o-Y growth rate of ~ 10% during the forecast period.

Although many effective meningococcal vaccines have already been developed, persistent product gaps still remain. Creating stable meningococcal vaccine supply in developing countries provides significant growth opportunities for the manufacturers of meningococcal vaccines.

To ensure stable supply, manufacturers must look for committed financing, high-quality manufacturing capacity, strong regulatory systems, and predictable demand. This also provides opportunities for local or regional players to partner with global players and stimulate procurement, as well as penetrate markets with high unmet needs.

Collaborations between multiple firms to evaluate and develop meningococcal vaccines and new supply and healthcare funding models are becoming progressively necessary to respond resourcefully to emergency outbreaks of infectious diseases such as meningococcal disease.

Even after powerful competition in high-value vaccines markets, collaborations with emerging and developing countries is becoming complex, and the involvement of multiple manufacturers as well as private- and public-sector investments are essential for developing new resistive meningococcal vaccines against emerging infectious diseases.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3640

Balanced Supply to Developed and Developing Regional Markets to Ensure Sustained Immunization

There is evidence that augmented demand for Gavi-aided meningococcal vaccines is encouraging the entry of a larger number of suppliers into the vaccine market. This is encouraging competition among players following the entry of new technologies into the market.

Gavi’s support is based on a country’s ability to pay, as it intends to put countries on a trajectory toward financial sustainability. The co-financing commitments of a country increases its national income until it reaches a threshold. At the end of this process, countries are fully self-financing vaccines.

Every year, some countries are entering into an accelerated transition phase. For instance, 16 countries, which include Vietnam, Cuba, Angola, Indonesia, Bhutan, Honduras, Mongolia, Sri Lanka, etc., entered into a transition phase and reached the end of the full self-financing stage.

This is expected to ensure equal immunization coverage across the globe and create growth opportunities in emerging meningococcal vaccine markets. The manufacturers of meningococcal vaccines are gradually focusing on value-driven services to boost their market penetration.

The addition of meningococcal vaccines to national immunization programs is expected to ensure the sustainable and affordable supply of these vaccines in the public as well as private sectors. This is estimated to accelerate the demand for meningococcal vaccines among the pediatric age group, thus contributing to meningococcal vaccine market growth.

In addition, the expansion of the indication of certain meningococcal vaccines for use in certain age groups can be partially attributed to the growing consumption of meningococcal vaccine units across the globe.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3640

For instance, in February 2018, the Ministry of Health, Government of Australia announced the upgradations of NIP to add Nimenrix-quadrivalent ACWY vaccines to the national immunization program of Australia. In July 2018, the Ministry of Health France declared that immunization with MenC vaccines is obligatory for all young children effective from 2018. Moreover, in 2014, single-dose meningococcal vaccine was added to the national immunization program of Pakistan.

PMR has segmented the global market for meningococcal vaccine based on product type, age group, distribution channel, and region. By product type, the market for meningococcal vaccine is further segmented into Serogroup B Meningococcal Vaccine (MenB-FHpb/MenB-4C), Meningococcal Conjugate Vaccine (MCV4) and Meningococcal Polysaccharide Vaccine (MPSV4). On the basis of age group, the meningococcal vaccine market is further segmented into Infants (0-24 months), Children, Adolescents and Young Adults, and Adults.

On the basis of distribution channel, the meningococcal vaccine market is segmented into Retail Sales and Institutional Sales. The institutional sales segment is further classified into Community Clinics, Public Health Agencies and Hospitals.

By region, the meningococcal vaccine market is segment into Europe, Latin America, North America, South Asia, East Asia, Oceania, and the Middle East & Africa. The report tracks some of the major companies operating in the meningococcal vaccine market, which include GlaxoSmithKline Biologicals SA, Sanofi Pasteur SA, Wyeth Pharmaceuticals Inc. (a subsidiary of Pfizer Inc.), and Serum Institute of India Ltd.

Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Persistence Market Research, as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Meningococcal Vaccines Market to scale high in the next decade here

News-ID: 2249858 • Views: 313

More Releases from Persistence Market Research

The Outpatient Home Therapy Market to witness an overall with respect to growth …
Outpatient home therapy provides treatment at the patient’s home. There need for outpatient home therapy is growing and more facilities are added to the services. Outpatient home therapy provides extra comfort to the patients and is regulated by the Medicare and Medicaid programs. Home therapy is useful when patients are not able to travel to the healthcare units due to lack of transportation or the patient may not be able
The Immunoassay Interference Blocker Market to be on the escalation mode in the …
The rapidly increasing prevalence of chronic diseases and the growth of the aging population across the world are among factors that are expected to increase the need for biochemical testing for the management of chronic diseases. The global increase in aging population is expected to increase the demand for diagnostic kits and reagents for the detection of age-related as well as other chronic conditions, which is expected to boost the
The Orthopedic Surgical Robots Market to foresee growth in the next 10 years
Orthopedic surgical robots have gained immense popularity over the years. Consistent advancements in the technology for orthopedic surgical robots, the availability of orthopedic surgical robots across the globe, and increase in government funding and investments by manufacturers for the development of orthopedic surgical robots are among the primary factors that are anticipated to fuel the demand for orthopedic surgical robots during the forecast period. According to the latest research by PMR,
The Endodontic Reparative Cement Market to spell a noteworthy growth in the next …
A recent published report by PMR, titled, ‘ Endodontic Reparative Cement Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029’, reviews the major factors influencing the structure of the endodontic reparative cement market. According to the study, endodontic reparative cement is a vital part of the growing dental care industry. Research shows that, dental care, on a global level, is in a period of transformation. The global population is aging and

All 5 Releases


More Releases for Health

Health literacy: How to improve health behaviors
Health literacy is defined as "people´s knowledge, motivation and competences to access, understand, appraise and apply information to make judgements and take decisions in everyday life healthcare concerning disease prevention and health promotion to maintain and improve quality of life during the life course." In a new volume Anne-Kathrin Mayer and colleagues shed light on the concept of health literacy from different disciplines: psychology, educational sciences, health sciences and
Mental Health 2019
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders or rub elbows with pioneers across the globe. London is all set for an amazing event as PULSUS proudly presents the “World Congress on Mental Health” scheduled on November 13,14, 2019 at London, UK. PULSUS cordially welcome researchers, academicians, students and business professionals in the field
GetSavvi Health - For Health Insurance Needs
GetSavvi Health offers health insurance, which includes basic and primary care at affordable prices. The company believes in the fact that South Africans are hard working and each of them deserve access to affordable and high-quality healthcare facilities and that too at affordable prices. The company desires to be a leader in the primary healthcare sector. Primary care is all about basic healthcare facilities through day-to-day benefits, which help in
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, …
ReportsWeb.com has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification. This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market,
MENTAL HEALTH NURSING, PUBLIC HEALTH AND HEALTH CARE SUMMIT
Psychiatric and Mental Health Nursing 2019 will prove to be a noteworthy event, with this we cherish mental health nursing by embracing the theme, “Fore-fronting nursing care to achieve mental wellness” , and would step forward to provide an opportunity to step in and join our family, as we bring and encourage to join professionals from the following areas of Mental Health, Psychology, Nursing, Physiology, Neurology, Healthcare, Education, Business to
TrendSights Analysis: Guided Health
"TrendSights Analysis: Guided Health", explores what the Guided Health trend is, why it is important, who is most influenced by it, and how brands and manufacturers can capitalize on it. The research concludes by identifying where the trend is heading next and how long it will last. In the information economy, health-conscious consumers now more confidently embrace an abundance of new information tools, enabling more health-driven choices. Consumers are seeking conveniences